Biogen Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2017 | $235.2M | $25.2M | $210.0M | $37.0M |
| Jun 2017 | $1.17B | $971.5M | $197.7M | $30.3M |
| Sep 2017 | $1.63B | $1.40B | $229.1M | $30.1M |
| Dec 2017 | $1.52B | $1.29B | $230.6M | $30.6M |
| Mar 2018 | $1.46B | $1.26B | $194.7M | $43.4M |
| Jun 2018 | $1.10B | $912.5M | $186.8M | $38.3M |
| Sep 2018 | $1.74B | $1.57B | $163.2M | $37.3M |
| Dec 2018 | $1.90B | $1.67B | $225.9M | $38.5M |
| Mar 2019 | $1.46B | $1.33B | $127.1M | $45.7M |
| Jun 2019 | $1.96B | $1.78B | $186.9M | $52.3M |
| Sep 2019 | $1.69B | $1.60B | $90.1M | $45.9M |
| Dec 2019 | $1.96B | $1.85B | $110.4M | $38.4M |
| Mar 2020 | $1.47B | $1.32B | $149.7M | $67.7M |
| Jun 2020 | $1.95B | $1.84B | $105.0M | $48.1M |
| Sep 2020 | $1.18B | $1.10B | $84.1M | $33.5M |
| Dec 2020 | $-367.1M | $-453.1M | $86.0M | $49.0M |
| Mar 2021 | $769.0M | $676.4M | $92.6M | $70.0M |
| Jun 2021 | $1.23B | $1.16B | $71.9M | $54.1M |
| Sep 2021 | $805.3M | $763.3M | $42.0M | $55.7M |
| Dec 2021 | $838.3M | $786.7M | $51.6M | $58.8M |
| Mar 2022 | $161.8M | $103.9M | $57.9M | $67.6M |
| Jun 2022 | $736.5M | $699.6M | $36.9M | $55.7M |
| Sep 2022 | $661.0M | $601.9M | $59.1M | $63.6M |
| Dec 2022 | $-175.0M | $-261.4M | $86.4M | $67.2M |
| Mar 2023 | $455.3M | $388.7M | $66.6M | $75.6M |
| Jun 2023 | $487.0M | $416.0M | $71.0M | $71.5M |
| Sep 2023 | $592.4M | $518.2M | $74.2M | $62.2M |
| Dec 2023 | $12.5M | $-52.7M | $65.2M | $54.9M |
| Mar 2024 | $553.2M | $507.3M | $45.9M | $72.8M |
| Jun 2024 | $625.8M | $592.3M | $33.5M | $70.6M |
| Sep 2024 | $935.6M | $900.6M | $35.0M | $72.7M |
| Dec 2024 | $760.9M | $721.6M | $39.3M | $75.1M |
| Mar 2025 | $259.3M | $222.2M | $37.1M | $81.0M |
| Jun 2025 | $160.9M | $134.3M | $26.6M | $74.9M |
| Sep 2025 | $1.27B | $1.23B | $46.2M | $75.3M |
| Dec 2025 | $511.9M | $468.0M | $43.9M | $59.6M |
| Mar 2026 | $645.5M | $594.3M | $51.2M | $84.0M |